InMed Announces Expected Merger Closing and Nasdaq Trading Under Mentari Therapeutics Name
InMed says the company is now Mentari Therapeutics, Inc., with trading on Nasdaq under ticker MTRI. The headline describes the closing as expected.
Story updates
09:02:07 PM UTC
SquawkNews
InMed Pharmaceuticals expects its merger with Mentari Therapeutics to close Nov. 6, subject to remaining conditions. Trading under the Mentari Therapeutics name and MTRI symbol is expected to begin Nov. 9.Material DetailsContext by AI AnalystThis is a near-term transaction milestone following the p…
Vancouver, British Columbia--(. - November 5, 2026) - InMed Pharmaceuticals Inc. NASDAQ:INM (now Mentari Therapeutics, Inc.) (the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical nee…